Alexander D MacKerell, Jr

This inventor holds 24 USPTO granted patents and 13 published patent applications and 2 EPO patents. Top assignees: University System of Maryland, The United States Government as Represented by the Department of Veterans Affairs, Albert Einstein College of Medicine. Active years: 2011-2026.

USPTO Granted Patents = 24 (Patent Applications = 13)

% Patents Active = 66.7

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 87(Granted Patents)

Company Filing History:

21 out of 2,023

University System of Maryland

patents

5 out of 955

The United States Government as Represented by the Department of Veterans Affairs

patents

1 out of 513

Albert Einstein College of Medicine

patents

4. 1 out of 1,363

Case Western Reserve University

Gen1e Lifesciences Inc.

patents

7. 1 out of 942

The University of New Mexico

patents

8. 1 out of 5,630

The University of Texas System

patents

9. 1 out of 311

University Health Network

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734176 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2026-09-15),

2. 12404259 - Inhibitors of extracellular signal-regulated kinase (2025-09-02),

3. 12202810 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2025-01-21),

4. 11911393 - Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

5. 11911392 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

6. 11718595 - Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors (2023-08-08),

7. 11634381 - RUNX2 transcription factor inhibitors and uses thereof (2023-04-25),

8. 11510908 - Protein translation inhibitors and uses thereof (2022-11-29),

9. 11357781 - Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2022-06-14),

10. 11078171 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2021-08-03),

11. 10002228 - Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation) (2018-06-19),

12. 9943506 - BCL6 inhibitors as anticancer agents (2018-04-17),

13. 9757375 - Compounds that inhibit human DNA ligases and methods of treating cancer (2017-09-12),

14. 9701627 - LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders (2017-07-11),

15. 9422302 - Mixed μ agonist/ δ antagonist opioid analgesics with reduced tolerance liabilities and uses thereof (2016-08-23),

Title: Alexander D MacKerell, Jr: A Pioneer in Inventive Solutions

Introduction: Alexander D MacKerell, Jr is a distinguished inventor based in Baltimore, MD, known for his groundbreaking contributions to the field of innovations and patents.

Latest Patents: Alexander D MacKerell, Jr holds several recent patents in the areas of pharmaceuticals and computational chemistry, showcasing his ongoing commitment to advancing scientific knowledge.

Career Highlights: With a career spanning over three decades, Alexander D MacKerell, Jr has established himself as a leading figure in the world of inventions. His work has been instrumental in shaping the way we approach complex scientific challenges.

Collaborations: Throughout his career, Alexander D MacKerell, Jr has collaborated with top research institutions, universities, and companies to bring his innovative ideas to life. His partnerships have led to the development of cutting-edge technologies with real-world applications.

Conclusion: Alexander D MacKerell, Jr's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the field of inventions. His work continues to inspire and drive progress in the scientific community.